Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J McLachlan

Showing results (21-30 of 497) with videos related to

Pageof 50
Sort By:
Biological Reviews of the Cambridge Philosophical Society|December 17, 2008
The evolutionary ecology of detritus feeding in the larvae of freshwater DipteraAthol J McLachlan, Richard J Ladle
Biomedical Chromatography : BMC|June 22, 2000
Determination of terbinafine in tissuesM H Yeganeh, A J McLachlan
Current Opinion in Infectious Diseases|September 18, 2014
Optimizing azole antifungal therapy in the prophylaxis and treatment of fungal infectionsMichael J Dolton, Andrew J McLachlan
Therapeutic Drug Monitoring|August 26, 1998
Effect of metabolic inhibitors on cyclosporine pharmacokinetics using a population approachA J McLachlan, S E Tett
Statistics in Medicine|March 26, 2003
An EM-based semi-parametric mixture model approach to the regression analysis of competing-risks dataS K Ng, G J McLachlan
Antimicrobial Agents and Chemotherapy|June 19, 2002
Physiologically based pharmacokinetic model for terbinafine in rats and humansMahboubeh Hosseini-Yeganeh, Andrew J McLachlan
Drugs|June 7, 2000
[Properties and features of nabumetone]N M Davies, A J McLachlan
The Journal of Pharmacy and Pharmacology|April 5, 2012
Investigating paracetamol pharmacokinetics using venous and capillary blood and saliva samplingAnneliese M Rittau, Andrew J McLachlan
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|August 13, 2011
Drug metabolism in older people--a key consideration in achieving optimal outcomes with medicinesAndrew J McLachlan, Lisa G Pont
British Journal of Clinical Pharmacology|April 1, 1996
Pharmacokinetics of fluconazole in people with HIV infection: a population analysisA J McLachlan, S E Tett
Pageof 50

Showing results (21-30 of 497) with videos related to

Sort By:
Pageof 50
Biological Reviews of the Cambridge Philosophical Society|December 17, 2008
The evolutionary ecology of detritus feeding in the larvae of freshwater DipteraAthol J McLachlan, Richard J Ladle
Biomedical Chromatography : BMC|June 22, 2000
Determination of terbinafine in tissuesM H Yeganeh, A J McLachlan
Current Opinion in Infectious Diseases|September 18, 2014
Optimizing azole antifungal therapy in the prophylaxis and treatment of fungal infectionsMichael J Dolton, Andrew J McLachlan
Therapeutic Drug Monitoring|August 26, 1998
Effect of metabolic inhibitors on cyclosporine pharmacokinetics using a population approachA J McLachlan, S E Tett
Statistics in Medicine|March 26, 2003
An EM-based semi-parametric mixture model approach to the regression analysis of competing-risks dataS K Ng, G J McLachlan
Antimicrobial Agents and Chemotherapy|June 19, 2002
Physiologically based pharmacokinetic model for terbinafine in rats and humansMahboubeh Hosseini-Yeganeh, Andrew J McLachlan
Drugs|June 7, 2000
[Properties and features of nabumetone]N M Davies, A J McLachlan
The Journal of Pharmacy and Pharmacology|April 5, 2012
Investigating paracetamol pharmacokinetics using venous and capillary blood and saliva samplingAnneliese M Rittau, Andrew J McLachlan
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|August 13, 2011
Drug metabolism in older people--a key consideration in achieving optimal outcomes with medicinesAndrew J McLachlan, Lisa G Pont
British Journal of Clinical Pharmacology|April 1, 1996
Pharmacokinetics of fluconazole in people with HIV infection: a population analysisA J McLachlan, S E Tett
Pageof 50